|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 329.90 DKK | -1.76% |
|
+2.37% | +1.43% |
| 06:18pm | Abbott investigates two separate cyber incidents, says no operations affected | RE |
| 07-17 | Novo Nordisk to launch lower-cost Ozempic copy in South Africa | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NOVO NORDISK A/S | Other Pharmaceuticals | -1.76% | +2.37% | +1.43% | -22.19% | +18.71% | 227B |  |  | |
- Stock Market
- Stocks
- NOVO B Stock
- Charts Novo Nordisk A/S
- Comparison Chart
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition